Arctic Bioscience - Invitation to capital markets update - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Arctic Bioscience - Invitation to capital markets update

Arctic Bioscience is pleased to invite investors, analysts, media and other stakeholders to a Capital Markets Update on 21 September 2022 in Oslo.

Presentations will be held by Arctic Bioscience management and external experts. The presentations and the following Q&A session will be held in Norwegian. The session will end with serving of a light lunch and mingling.

The event will take place at Flyt Conference Centre, Haakon VIIs gate 2 from 10.00 – 12.00 CEST

A recording of the event will be available on the company’s web site after the event.

To registrate your participance for the event, please send an email to Jone R. Slinning: jone@arctic-bioscience.com.

Tentative agenda

  • Introduction and company presentation - Christer Valderhaug, CEO Arctic Bioscience
  • Psoriasis symptom relief through Herring Caviar Oil - Dr. Kåre Steinar Tveit, Chief Physician Haukeland University Hospital
  • Arctic Bioscience Pharmaceutical Development Program  - Runhild Gammelsæter, Medical Director Arctic Bioscience
  • Brain development in extremely premature infants - Smerud Medical Research - Knut Smerud, Founder & CEO Smerud Medical Research
  • DHA, Alfa & Omega for The Brain - Ole Petter Hjelle, MD PhD
  • Closing remarks & Q&A - CEO Christer Valderhaug, Medical Director Runhild Gammelsæter, CFO Jone R. Slinning

Nyheter om Arctic Bioscience

Läses av andra just nu

Om aktien Arctic Bioscience

Senaste nytt